Combined technology solution evaluates study data within the EDC system against contract criteria and generates financial transactions and all related accounting information
Clinverse, Inc.
, a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with
OmniComm Systems, Inc.
, a provider of EDC solutions.
Clinverse’s ClinPay solution automates sponsor payments to clinical vendors, investigators, and other parties throughout the entire financial lifecycle of a clinical trial. OmniComm’s TrialMaster EDC suite automates data collection and data validation and offers the unique capabilities of centralized monitoring with auto-redaction and automated SDTM export utility, allowing for efficient and cost-effective trial management.
Together with ClinPay, the combined solution automatically evaluates study data within the EDC system against contract criteria and directly generates financial transactions and all related accounting information. This combination optimizes cost savings by streamlining an inherently error-prone manual process and substantially reduces labor costs associated with the payment and accounting process for clinical vendors and investigative sites.
“We are pleased to be in a strategic partnership with such an innovative and forward-thinking EDC provider as OmniComm,” said Steve Ayala, Clinverse President and head of strategic partnerships. “OmniComm’s global footprint expands Clinverse’s reach to a broader international audience of pharmaceutical and biotech companies, CROs, research, and medical device organizations that can greatly benefit from automated payment capabilities in conjunction with their EDC services.”
Clinverse’s open application programming interface (API) allows for seamless integration with existing systems, such as OmniComm’s TrialMaster suite, as well as other external eclinical data sources, such as CTMS, IxRS, ERP systems, and data warehouses. When integrated with OmniComm’s TrialMaster EDC, sponsors and/or CROs are assured that accurate and direct financial transaction data feeds are automatically routed through the appropriate channels resulting in consistent and timely payments, whether by procedure,visit or any other contracted term.
“Most of the clinical sites we work with are required to use multiple EDC systems for various studies. Two of their biggest frustrations are the lack of intuitiveness of most EDC systems and the need for accurate and timely study payments,” stated Kuno van der Post, SVP of Business Development, OmniComm Systems, Inc. “Partnering with Clinverse and offering our TrialMaster EDC alongside their ClinPay solution allows us to make an exceptionally positive impact at the sites by addressing both of these key concerns.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.